MSU
ALXN

Mizuho Securities USA’s Alexion Pharmaceuticals ALXN Stock Holding History

Mizuho Securities USA’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-5,810
Closed -$1.01M – 269
2015
Q1 		$1.01M Sell
5,810
-112
-2% -$20.3K 0.13% 105
2014
Q4 		$1.1M Buy
+5,922
New +$1.1M 0.11% 98
2014
Q1 		– Sell
-23,667
Closed -$3.15M – 124
2013
Q4 		$3.15M Buy
23,667
+6,802
+40% +$816K 0.26% 65
2013
Q3 		$1.96M Sell
16,865
-2,887
-15% -$317K 0.12% 71
2013
Q2 		$1.82M Buy
+19,752
New +$1.9M 0.09% 74

Other funds holding ALXN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Mizuho Securities USA's ALXN Position: Q2 2015 in Review

Mizuho Securities USA sold out of Alexion Pharmaceuticals (ALXN) in Q2 2015, closing a stake of 5,810 shares — an estimated $1.01M sold.

Mizuho Securities USA first reported a position in ALXN in Q2 2013 and held it in 5 quarters. The position peaked at $3.15M in Q4 2013. 548 funds tracked by Wall St. Rank hold ALXN as of Q2 2015.

  • Mizuho Securities USA reported no remaining Alexion Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Mizuho Securities USA sold 5,810 Alexion Pharmaceuticals shares in Q2 2015, an estimated $1.01M.
  • Mizuho Securities USA first reported a position in Alexion Pharmaceuticals in Q2 2013 and held it in 5 quarters.
  • Mizuho Securities USA's Alexion Pharmaceuticals position peaked at $3.15M in Q4 2013.
  • 548 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q2 2015.

Based on Mizuho Securities USA's 13F filing for Q2 2015, filed 20 Jul 2015.